Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Xue

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|May 9, 2025
Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: Focusing on the primitive enterocyte phenotype and PVRBingzhi Wang, Yinong Wang, Yongjian Zhu, et al.
Cancer Letters|February 20, 2026
Spatially Resolved Transcriptomics Identifies Tumor-Stroma-Immune Networks and Therapeutic Targets in Endocrine-Resistant Advanced Breast Cancer Treated with Everolimus+Letrozole: Insights from the MIRACLE TrialXuemin Xue, Danyang Ji, Liyan Xue, et al.
Gastrointestinal Endoscopy|August 16, 2011
Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagusJacques J G H M Bergman, Yue-Ming Zhang, Shun He, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Long segmental hyperplasia of interstitial cells of Cajal with giant diverticulum formationLiyan Xue, Tian Qiu, Ying Song, et al.
International Journal of Surgery (London, England)|March 28, 2023
Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in ChinaChaoqi Zhang, Guochao Zhang, Liyan Xue, et al.
Journal of Cancer Research and Clinical Oncology|May 20, 2021
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in ChinaGuochao Zhang, Chaoqi Zhang, Nan Sun, et al.
British Journal of Cancer|October 7, 2022
A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategyLiyan Xue, Zitong Zhao, Minjie Wang, et al.
Frontiers in Immunology|February 10, 2023
Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysisYunsong Liu, Yongxing Bao, Xu Yang, et al.
The Lancet Regional Health. Western Pacific|September 22, 2025
The design and evaluation of the opportunistic endoscopic screening (OpENS) program for upper gastrointestinal tract cancers: a real-world study in ChinaKexin Sun, Shun He, Huadong Wang, et al.
Journal of the National Cancer Center|July 22, 2024
Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinomaZhen Wang, Xiankai Chen, Yong Li, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|May 9, 2025
Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: Focusing on the primitive enterocyte phenotype and PVRBingzhi Wang, Yinong Wang, Yongjian Zhu, et al.
Cancer Letters|February 20, 2026
Spatially Resolved Transcriptomics Identifies Tumor-Stroma-Immune Networks and Therapeutic Targets in Endocrine-Resistant Advanced Breast Cancer Treated with Everolimus+Letrozole: Insights from the MIRACLE TrialXuemin Xue, Danyang Ji, Liyan Xue, et al.
Gastrointestinal Endoscopy|August 16, 2011
Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagusJacques J G H M Bergman, Yue-Ming Zhang, Shun He, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Long segmental hyperplasia of interstitial cells of Cajal with giant diverticulum formationLiyan Xue, Tian Qiu, Ying Song, et al.
International Journal of Surgery (London, England)|March 28, 2023
Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in ChinaChaoqi Zhang, Guochao Zhang, Liyan Xue, et al.
Journal of Cancer Research and Clinical Oncology|May 20, 2021
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in ChinaGuochao Zhang, Chaoqi Zhang, Nan Sun, et al.
British Journal of Cancer|October 7, 2022
A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategyLiyan Xue, Zitong Zhao, Minjie Wang, et al.
Frontiers in Immunology|February 10, 2023
Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysisYunsong Liu, Yongxing Bao, Xu Yang, et al.
The Lancet Regional Health. Western Pacific|September 22, 2025
The design and evaluation of the opportunistic endoscopic screening (OpENS) program for upper gastrointestinal tract cancers: a real-world study in ChinaKexin Sun, Shun He, Huadong Wang, et al.
Journal of the National Cancer Center|July 22, 2024
Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinomaZhen Wang, Xiankai Chen, Yong Li, et al.
Pageof 18